Results 131 to 140 of about 1,652 (181)

Synthetic lethality in cancer: mechanism exploration and therapeutic applications. [PDF]

Cell Commun Signal
Zhao P, Wang P, Xu T, Chen L, Jia Q, Li M.   +5 more
europepmc   +1 more source

Advances in molecular glue degraders for targeted protein degradation: Focus on NEK7, WEE1, CDK2, GSPT1 and VAV1. [PDF]

Asian J Pharm Sci
Cheng B, Wang Y, Hong Y, Zhou Y, Peng X, Chen J, Zeng C.   +6 more
europepmc   +1 more source

G-quadruplex stabilization induces DNA breaks in pericentromeric repetitive DNA sequences in B lymphocytes. [PDF]

Proc Natl Acad Sci U S A
Waisertreiger I, Ayele K, Elshaikh MH, Barlow JH.   +3 more
europepmc   +1 more source

A nu mouse model of diffuse large B-cell lymphoma in constitutional Atm loss. [PDF]

Haematologica
Hilton LK.
europepmc   +1 more source

Drug-tolerant persister cells: the deadly survivors in hematological malignancies. [PDF]

Front Pharmacol
Ma Q, Cao T, Zhou L, Cheng J, Zhao L.
europepmc   +1 more source

Current Research in Polypharmacology for Cancer Treatment Using Dual-Target Histone Deacetylase Inhibitors. [PDF]

Int J Mol Sci
Yudaev P, Aleksandrova Y, Neganova M.
europepmc   +1 more source

cGAS-STING pathway in lung cancer and emerging therapeutic approaches. [PDF]

Drug Discov Today
Joshi A, Izgu EC.
europepmc   +1 more source

Sensitizing Colorectal Cancer to PARP Inhibitors: Biomarkers, Mechanisms, and Combination Strategies. [PDF]

Int J Mol Sci
Elesnawy M, Masood E, Naik A.
europepmc   +1 more source

Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. [PDF]

Oncogene
Chao Y, Chen Y, Zheng W, Demanelis K, Liu Y, Connelly JA, Wang H, Li S, Wang QJ.   +8 more
europepmc   +1 more source

WEE1 Inhibitors Mediate Antitumor Effects on Endometrial Cancer through Activation of Innate Immune Responses. [PDF]

J Cancer
Li Y, Wang X, Hou X, Wu M, Wang S, Ma X.
europepmc   +1 more source